Total Payments
$12,080
2024 Payments
$1,456
Companies
50
Transactions
878
Medicare Patients
8,046
Medicare Billing
$390,827
Payment Breakdown by Category
Food & Beverage$12,039 (99.7%)
Other$28.80 (0.2%)
Education$12.35 (0.1%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $12,039 | 874 | 99.7% |
| Entertainment | $28.80 | 2 | 0.2% |
| Education | $12.35 | 2 | 0.1% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Novo Nordisk Inc | $2,218 | 161 | $0 (2024) |
| ABBVIE INC. | $1,069 | 104 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $914.51 | 39 | $0 (2024) |
| Lilly USA, LLC | $869.04 | 78 | $0 (2024) |
| PFIZER INC. | $847.61 | 70 | $0 (2024) |
| Amgen Inc. | $638.39 | 45 | $0 (2023) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $533.01 | 36 | $0 (2023) |
| Merck Sharp & Dohme LLC | $455.13 | 36 | $0 (2024) |
| SANOFI-AVENTIS U.S. LLC | $342.83 | 22 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $294.72 | 26 | $0 (2021) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,456 | 101 | Novo Nordisk Inc ($230.81) |
| 2023 | $1,734 | 108 | Novo Nordisk Inc ($262.89) |
| 2022 | $2,081 | 147 | ABBVIE INC. ($382.57) |
| 2021 | $1,601 | 119 | Novo Nordisk Inc ($281.93) |
| 2020 | $946.84 | 65 | Novo Nordisk Inc ($241.94) |
| 2019 | $2,547 | 197 | Novo Nordisk Inc ($596.89) |
| 2018 | $1,521 | 128 | Novo Nordisk Inc ($243.26) |
| 2017 | $192.55 | 13 | PFIZER INC. ($59.87) |
All Payment Transactions
878 individual payment records from CMS Open Payments — Page 1 of 36
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/24/2024 | Currax Pharmaceuticals LLC | CONTRAVE (Drug) | Food and Beverage | In-kind items and services | $8.15 | General |
| Category: Obesity | ||||||
| 12/17/2024 | Currax Pharmaceuticals LLC | CONTRAVE (Drug) | Food and Beverage | In-kind items and services | $5.82 | General |
| Category: Obesity | ||||||
| 12/11/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $12.18 | General |
| Category: NEUROSCIENCE | ||||||
| 12/11/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $7.62 | General |
| Category: Diabetes | ||||||
| 12/06/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $19.41 | General |
| Category: Diabetes | ||||||
| 11/25/2024 | Novo Nordisk Inc | — | Food and Beverage | In-kind items and services | $21.43 | General |
| 11/14/2024 | PFIZER INC. | PREVNAR 20 (Biological), COMIRNATY, ABRYSVO | Food and Beverage | In-kind items and services | $13.18 | General |
| Category: VACCINES | ||||||
| 11/13/2024 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $21.49 | General |
| Category: Diabetes | ||||||
| 11/11/2024 | Currax Pharmaceuticals LLC | CONTRAVE (Drug) | Food and Beverage | In-kind items and services | $4.74 | General |
| Category: Obesity | ||||||
| 11/05/2024 | ABBVIE INC. | QULIPTA (Drug), BOTOX | Food and Beverage | In-kind items and services | $4.31 | General |
| Category: NEUROSCIENCE | ||||||
| 11/05/2024 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $0.18 | General |
| Category: BOTOX THERAPEUTIC | ||||||
| 10/29/2024 | Medtronic, Inc. | MINIMED 780G (Device) | Food and Beverage | In-kind items and services | $72.99 | General |
| Category: Durable Pump | ||||||
| 10/28/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug), XIFAXAN | Food and Beverage | In-kind items and services | $14.86 | General |
| Category: Gastroenterology | ||||||
| 10/24/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $12.59 | General |
| Category: NEUROSCIENCE | ||||||
| 10/23/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $17.35 | General |
| Category: Diabetes | ||||||
| 10/22/2024 | SANOFI-AVENTIS U.S. LLC | TZIELD (Biological) | Food and Beverage | In-kind items and services | $21.09 | General |
| Category: Endocrine & Metabolic Diseases | ||||||
| 10/21/2024 | Currax Pharmaceuticals LLC | CONTRAVE (Drug) | Food and Beverage | In-kind items and services | $5.60 | General |
| Category: Obesity | ||||||
| 10/17/2024 | GlaxoSmithKline, LLC. | AREXVY (Drug), SHINGRIX | Food and Beverage | In-kind items and services | $24.54 | General |
| Category: RESPIRATORY | ||||||
| 10/10/2024 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Food and Beverage | In-kind items and services | $14.66 | General |
| Category: Respiratory | ||||||
| 10/09/2024 | Currax Pharmaceuticals LLC | CONTRAVE (Drug) | Food and Beverage | In-kind items and services | $5.82 | General |
| Category: Obesity | ||||||
| 10/08/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $9.33 | General |
| Category: Diabetes | ||||||
| 10/04/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $11.43 | General |
| Category: NEUROSCIENCE | ||||||
| 10/04/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $7.10 | General |
| Category: Diabetes | ||||||
| 10/01/2024 | Astellas Pharma US Inc | Veozah (Drug) | Food and Beverage | In-kind items and services | $16.93 | General |
| Category: Biological | ||||||
| 09/26/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $15.60 | General |
| Category: Cardio-renal | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 32 | 1,724 | 2,241 | $156,247 | $78,418 |
| 2022 | 36 | 2,223 | 2,838 | $186,712 | $95,459 |
| 2021 | 32 | 2,184 | 2,888 | $197,382 | $110,677 |
| 2020 | 33 | 1,915 | 2,591 | $200,183 | $106,273 |
Total Patients
8,046
Total Services
10,558
Medicare Billing
$390,827
Procedure Codes
133
All Medicare Procedures & Services
133 procedure records from CMS Medicare Utilization — Page 1 of 6
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 174 | 299 | $50,830 | $23,179 | 45.6% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 180 | 180 | $31,500 | $21,838 | 69.3% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 109 | 170 | $20,400 | $8,462 | 41.5% |
| 99496 | Transitional care management services for problem of high complexity | Office | 2023 | 20 | 22 | $7,645 | $4,593 | 60.1% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2023 | 46 | 46 | $4,830 | $3,309 | 68.5% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 195 | 339 | $4,407 | $2,817 | 63.9% |
| 80061 | Blood test, lipids (cholesterol and triglycerides) | Office | 2023 | 118 | 121 | $4,356 | $1,576 | 36.2% |
| 83036 | Hemoglobin a1c level | Office | 2023 | 75 | 163 | $3,749 | $1,536 | 41.0% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 52 | 52 | $1,664 | $1,527 | 91.8% |
| 80048 | Blood test, basic group of blood chemicals (calcium, total) | Office | 2023 | 128 | 140 | $3,080 | $1,153 | 37.4% |
| 82306 | Vitamin d-3 level | Office | 2023 | 27 | 33 | $2,310 | $957.33 | 41.4% |
| 84153 | Psa (prostate specific antigen) measurement, total | Office | 2023 | 48 | 50 | $2,200 | $882.98 | 40.1% |
| 84443 | Blood test, thyroid stimulating hormone (tsh) | Office | 2023 | 49 | 53 | $1,855 | $872.38 | 47.0% |
| 83970 | Parathormone (parathyroid hormone) level | Office | 2023 | 17 | 20 | $2,500 | $809.00 | 32.4% |
| G0444 | Annual depression screening, 5 to 15 minutes | Office | 2023 | 45 | 45 | $1,035 | $758.56 | 73.3% |
| 85025 | Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count | Office | 2023 | 60 | 72 | $1,152 | $541.91 | 47.0% |
| 87088 | Bacterial urine culture | Office | 2023 | 32 | 54 | $1,188 | $428.22 | 36.0% |
| 82607 | Cyanocobalamin (vitamin b-12) level | Office | 2023 | 25 | 26 | $1,820 | $384.28 | 21.1% |
| 82746 | Folic acid level, serum | Office | 2023 | 24 | 25 | $1,675 | $360.25 | 21.5% |
| 84450 | Liver enzyme (sgot), level | Office | 2023 | 66 | 68 | $748.00 | $345.44 | 46.2% |
| G0009 | Administration of pneumococcal vaccine | Office | 2023 | 12 | 12 | $540.00 | $322.96 | 59.8% |
| 82728 | Ferritin (blood protein) level | Office | 2023 | 16 | 17 | $493.00 | $227.12 | 46.1% |
| 82043 | Urine microalbumin (protein) level | Office | 2023 | 38 | 38 | $1,178 | $210.00 | 17.8% |
| 80053 | Blood test, comprehensive group of blood chemicals | Office | 2023 | 19 | 20 | $500.00 | $207.00 | 41.4% |
| 82570 | Creatinine level to test for kidney function or muscle injury | Office | 2023 | 38 | 39 | $1,092 | $193.62 | 17.7% |
About Dr. Wayne Beam, MD
Dr. Wayne Beam, MD is a Family Medicine healthcare provider based in Chillicothe, Ohio. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/11/2006. The National Provider Identifier (NPI) number assigned to this provider is 1073548921.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Wayne Beam, MD has received a total of $12,080 in payments from pharmaceutical and medical device companies, with $1,456 received in 2024. These payments were reported across 878 transactions from 50 companies. The most common payment nature is "Food and Beverage" ($12,039).
As a Medicare-enrolled provider, Beam has provided services to 8,046 Medicare beneficiaries, totaling 10,558 services with total Medicare billing of $390,827. Data is available for 4 years (2020–2023), covering 133 distinct procedure/service records.
Ad
Practice Information
- Specialty Family Medicine
- Location Chillicothe, OH
- Active Since 07/11/2006
- Last Updated 01/29/2019
- Taxonomy Code 207Q00000X
- Entity Type Individual
- NPI Number 1073548921
Products in Payments
- Ozempic (Drug) $1,003
- VRAYLAR (Drug) $865.72
- FARXIGA (Drug) $494.94
- JARDIANCE (Drug) $492.22
- TRULICITY (Drug) $476.79
- Aimovig (Biological) $384.61
- ELIQUIS (Drug) $360.76
- Tresiba (Drug) $294.58
- TRINTELLIX (Drug) $257.52
- XIFAXAN (Drug) $253.58
- BREZTRI (Drug) $239.46
- REXULTI (Drug) $239.29
- Cologuard Collection Kit (Device) $237.78
- ENTRESTO (Drug) $235.16
- UBRELVY (Drug) $223.12
- Kerendia (Drug) $222.65
- Rybelsus (Drug) $220.80
- EMGALITY (Drug) $219.70
- XARELTO (Drug) $209.20
- CHANTIX (Drug) $199.65
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Medicine Doctors in Chillicothe
Dr. Jerry Kunz, Md, MD
Family Medicine — Payments: $13,791
Family Medicine $13,791
Jennifer Mowry-Fisk, Md, MD
Family Medicine — Payments: $10,635
Family Medicine $10,635
Azizur Rehman, Md, MD
Family Medicine — Payments: $3,641
Family Medicine $3,641
Dr. Gregory Sensenich, Do, DO
Family Medicine — Payments: $3,264
Family Medicine $3,264
Alan Noel, Md, MD
Family Medicine — Payments: $2,517
Family Medicine $2,517
Dr. Cynthia Hamm, M.d, M.D
Family Medicine — Payments: $2,299
Family Medicine $2,299